Part,  Chapter, Paragraph

1   II,     5.  3.  7|     review time for the marketing authorization of new innovative cancer
2   II,     5.  3.  7|   authorities.~· Ensure that once authorization is obtained, the drug is
3   II,     6.  4.  5|         dossier requested for any authorization to market antibiotics; b)
4  III,    10.  3.  2|         Registration, Evaluation, Authorization of Chemicals Register~Rh~
5  III,    10.  3.  2|         Registration, Evaluation, Authorization of Chemicals), a uniform
6   IV,    11.  3.  2| regulatory decisions about market authorization, pricing and reimbursement (
7   IV,    11.  3.  2|           harmonization of market authorization via the European Medicines
8   IV,    12.  1    |   manufacturing practices, market authorization, pricing, and reimbursement,
9   IV,    12.  1    |           harmonization of market authorization via the European Medicines